Cirrhosis whole other system performance

(1) a digestive system. Peptic ulcer disease combined with chronic liver disease who peptic ulcer disease was called liver ulcer disease (hepat (; - genitlc ulcer), the incidence of 15% to 30% higher than the general population. the majority of patients with typical clinical symptoms. statistics show that duodenal ulcers accounted for 80%. but ulcer liver disease and liver lesions degree, Severe chronic hepatitis C and cirrhosis Child-ulcer patients with liver disease rate is as high as 50 / ~ 7 (. 0.S . liver ulcer pathogenesis is not yet very clear. may stomach membrane attack new factor to enhance and protect the mission to the defense of multiple factors weakened the result. 2. cholelithiasis cirrhosis cholelithiasis patients with increased morbidity, 20% ~ 30). mainly for bile pigment guitar 6, right with hemolytic excretion of bile pigment disorders. not typical clinical manifestations. 3. almost all chronic cholecystitis suffering from cirrhosis those who have chronic cholecystitis, the majority of patients with non-bacterial, no characteristic clinical performance; a small number of patients may have it dull abdominal discomfort or liver discomfort. 4. portal hypertension enteropathy incidence rate of 30% ~ 40 %, the lack of specificity of clinical performance, some patients may have diarrhea, hematochezia so. its pathogenesis may portal hypertensive gastropathy similar. (2) an endocrine system. impaired glucose tolerance, diabetic patients with cirrhosis 60% to 80% of abnormal glucose tolerance, Among them, 15% ~ 20% performance obvious diabetes, some call it the liver-derived diabetes (hepatogenitic diabetes). the source of most of the liver diabetic patients with typical clinical performance, a small number of patients can be thirsty, a few drinks and chronic renal insufficiency and other diabetic complications performance. cirrhosis Insulin resistance is abnormal glucose tolerance and liver-derived diabetes the main reason for the disease. 2. hypoglycemia suggest the existence of hypoglycemia in patients with cirrhosis at least 80% of liver cells can no longer function. yes patients with advanced cirrhosis of the liver failure signal, but if the merger bacterial infections, liver, hypoglycemia can. Clinical manifestations can be as heart palpitations, sweating, even coma. the other three other serum thyroxine reduce T3 and rT3 increased, while the level of serum thyrotropin normal; no typical clinical performance. 2. (3) a nervous system. hepatic encephalopathy detailed in the relevant sections. 2. spinal cord liver disease hepatic ridge pulp disease incidence of 0.1% to 10%. in addition to the clinical performance of cirrhosis, mainly lasting abnormalities in the nervous system, performance for dual spastic paraplegia, slow onset, but sexual heavier, not with sensory dysfunction and muscle atrophy. its mechanism of liver cirrhosis with portal hypertension extensive collateral circulation. high ammonia and other toxic metabolites of the continuing rise. (4) a respiratory. See hepatopulmonary syndrome relevant sections. 2 . pulmonary hypertension in patients with liver cirrhosis pulmonary hypertension incidence of about 1%, portal shunt rate higher, clinical manifestations of the difficulty in breathing, chest pain, syncope, a small number of patients with hemoptysis. breastbone left margin of the first two intercostal and noises could be heard, 220 Green moving hyperthyroidism, its causes is not clear, with the portal hypertension. (5) Urinary System 1. See hepatorenal syndrome relevant sections. 2. hepatitis B virus-associated nephritis pieces of its occurrence rate of 5% to l0%. mechanism for the hepatitis B virus in the three-allergic. Early clinical manifestations of urinary protein, hematuria; there will be advanced renal failure azotemia. 3. "jaundice kidneys" because of bile acid or bile salt deposition due to the tubular the kidney disease, pathology is known as "jaundice" kidney. no specific clinical performance. Therefore, the diagnosis difficult. (6) the cardiovascular system in patients with cirrhosis the majority of light times higher systemic circulatory state, plasma volume increased a special row for its cardiac output increase. peripheral vascular resistance decreased. clinical manifestations of the hot hand, capillary beat, such hypotension and tachycardia. a small number of patients with chronic liver disease can be complicated by multiple nodules arteritis. reasons cited with HBsAg The three-allergic; clinical manifestations of cardiac enlargement, heart dysfunction, hypertension, muscle pain and other damages. (7) water and electrolyte metabolism disorders